Jayex, formerly known as Express Rx Limited, is an Australian unlisted public company which plans to own and control four key proprietary healthcare service delivery technology platforms that will combine to provide an integrated 'end-to-end' and 'state-of-the-art' healthcare services delivery system.

Jayex has an established, profitable Enlighten business in the UK to date, with a strategic footprint in Australia and New Zealand, and plans to expand into North America, and key Asian markets.

Jayex's suite of healthcare service delivery technologies is designed to meet the demands of patients for convenient, lower cost healthcare services tailored to their specific needs. The system also aims to enable general practitioners (GPs), allied healthcare professionals (AHPs), clinics, pharmacies and hospitals to provide better healthcare services more efficiently and at lower cost, with the potential for increased productivity and greater profitability for healthcare service providers.

It is anticipated that JHL will list on the ASX during December 2015.